Related Experiment Video
Updated: Aug 12, 2026

07:10
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Normal lymphocyte development but delayed humoral immune response in CD81-null mice
1Department of Medicine and Oncology, Stanford University Medical Center, California 94305, USA.
The Journal of Experimental Medicine
|April 21, 1997
Summary
CD81 is not essential for T cell development. However, CD81 deficiency impacts B cell function, reducing CD19 expression and antibody production efficiency.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- CD81 is a cell surface molecule involved in B cell signaling complexes.
- Previous research suggested CD81's role in thymocyte maturation.
Purpose of the Study:
- To investigate the role of CD81 in T cell and B cell development and function.
- To determine if CD81 is essential for thymocyte maturation.
Main Methods:
- Gene targeting to create CD81-null mice.
- Analysis of thymocyte, T cell, and B cell populations.
- Assessment of antibody responses to ovalbumin.
Main Results:
- CD81-null mice exhibit normal thymocyte and T cell development.
- B cell numbers are normal in CD81-null mice, but CD19 expression is reduced.
- Early antibody responses are weaker in CD81-null mice.
Conclusions:
- CD81 is not required for T cell maturation.
- CD81 plays a role in optimal CD19 expression on B cells.
- CD81 is important for efficient B cell antibody production.
Related Concept Videos
Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...

